October 5th, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know. You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

This week, I was pleased to moderate an engaging panel discussion at Reboot Communications' 23rd Annual Healthcare Summit, exploring how post-pandemic digital health solutions enhance access to efficient, quality mental healthcare services, benefiting all Canadians. Thanks to panelists Dr. Matthew Chow of Telus Health, Dr. Diane McIntosh of Rapids Health, Michel Rodrigue of the Mental Health Commission of Canada, and Chenny Xia of Gotcare for sharing your valuable insights!

LSBC also enjoyed attending last week's BioAlberta Health & Life Sciences Showcase, featuring engaging discussions on cutting-edge life sciences topics and celebrating outstanding Alberta companies. It’s heartening to collaborate with our provincial counterparts and bolster our shared presence on the global stage. This cooperative spirit exemplifies our Canadian life sciences community. Pictured are Ryan Butt, of LSBC, Rob Henderson of BioTalent Canada, and Robb Stoddard of BioAlberta.

Member Highlights 

Genome BC, in partnership with Thompson Rivers University (TRU), the University of British Columbia and the University of Northern British Columbia, has announced the launch of a pilot project to integrate genomics education into the new Master of Nursing – Nurse Practitioner program at TRU. This is the first initiative in Canada to incorporate precision health concepts and genomics education into nurse practitioner training for both students and faculty. Learn more.

BioTalent Canada has released its comprehensive “Biosciences Booster” report, which showcases the remarkable achievement of its Student Work Placement Program (SWPP), including 11K student placements in over 2K bioscience and healthcare organizations – including LSBC! BioTalent Canada is asking Canada to provide funding for SWPP on an ongoing and renewable basis each fiscal year. Read the report here.

Takeda Canada has introduced its Clinical Trials Lexicon, an app designed to grant healthcare professionals instant access to a comprehensive repository of essential studies and data. The initial release of this app is dedicated to Inflammatory Bowel Disease, with plans to include additional clinical focus areas in subsequent phases. Learn more.

Researchers from the UBC Faculty of Medicine have joined forces to conduct the inaugural nationwide investigation into RSV hospitalizations before and during the pandemic. This study underscores the impact of the virus on Canadian children and the pediatric healthcare system. Learn more.

A recent study conducted by Ascension Health examined the effects of transitioning from disposable sharps containers to reusable sharps container systems provided by Daniels Health Canada. Read about this case study and its findings here.

LifeLabs has launched its new Therapeutic Drug Monitoring service that offers personalized insights and tailored treatment plans based on accurate data. Learn more.

New Members

We are pleased to welcome the following new LSBC Members: 

SeraGene Therapeutics is an early-stage biotechnology company developing the next generation of gene and cell therapies to treat blood coagulation disorders, including bleeding and thrombosis.

RBCx scales and invests in technology companies and venture capital funds that are powering bold ideas across tech, life sciences, and climate sectors.

Daniels Health delivers the safest sharps containers in the world together with healthcare waste management services that are designed to drive clinical and infection control outcomes - Daniels is a partner to thousands of Canadian hospitals and healthcare facilities.

The Colliers Life Science Practice Group specializes in sourcing all levels of lab and manufacturing facilities for organizations. Their team offers detailed local market knowledge, industry expertise, and international connectivity to expedite complex business projects.

Welcome all to the LSBC community!

Industry Highlights

Canada’s Minister of International Trade, Export Promotion, and Economic Development delivered a speech at the 2023 Elevate Festival, the nation's largest technology and innovation festival, underscoring Canada's commitment to levelling the economic and entrepreneurship playing field for all Canadians and emphasizing the federal support for women entrepreneurs and Canada's inclusive stance on trade. Learn more.

Canada is investing strategically in globally-demanded local tech companies, including over 230 BC-based immersive tech firms. PacifiCan has recently pledged $312K in funding to support the Frontier Collective Society, which is pivotal in promoting BC's thriving tech sector, encompassing virtual and augmented reality, artificial intelligence, and clean and biotechnology globally. Learn more.



The Public Policy Forum has released its report "The Next One: Preparing Canada for Future Health Emergencies" with recommendations on preparedness, including procurement. The PPF's Life Sciences Forum (LSF) contributed to these policy ideas. Read the full report here. 

Kudos

Congratulations to the winners of this year’s BC Tech 2023 Technology Impact Awards (TIA). It was great to see such a strong representation from the biotech sector, and it's worth noting that our esteemed members claimed nearly half of these prestigious accolades! This includes Aspect Biosystems, which took home two awards: Company of the Year – Scale, and Gamechanger – Ambition. STEMCELL Technologies won Company of the Year – Anchor, and AbCellera won the award for Excellence in Industry Innovation. Kudos to all of this year's accomplished winners! To learn more about their outstanding contributions and to relive the event's highlights, click here. Congratulations also to BC Tech for celebrating 30 years!

Congratulations to Zymeworks for celebrating its 20^th anniversary this week! We applaud your incredible progress and accomplishments over the last two decades and look forward to future innovations!

Kudos to our members who were selected as 2023 finalists for the Citeline Scrip Awards in November. See the shortlisted companies here.

People on the Move

adMare BioInnovations welcomes three new board members: Martin LeBlanc of CellCarta Biosciences, Tim van Biesen of Bain & Company and John DeLucchi of Madison Venture Corporation. Learn more.

Berkley Canada has welcomed Catherine Felepchuk as VP of Distribution, Communication & Product.

Applications Open

Johnson & Johnson Innovation invites BC life sciences companies to apply for an exclusive one-on-one meeting on November 1^st! This opportunity aims to explore potential collaborations between entrepreneurs and Johnson & Johnson Innovation's global healthcare businesses. Applications are due Oct.11. Learn more.

BC life sciences companies also have an opportunity on Nov.1 to engage in one-on-one discussions with United Therapeutics, a pioneering biotech company at the forefront of revolutionary technologies in rare lung diseases, oncology, and organ manufacturing. Applications are due Oct. 6. Learn more here.

In partnership with Trade & Investment BC, the Osaka Prefectural Government invites BC life sciences companies to apply to their online B2B biotech and pharma networking event. They are seeking companies with strong capabilities in drug discovery, regenerative medicine, digital therapeutics and Medtech AI. This event provides an opportunity to interact with some of the largest pharma companies in the Western region of Japan, including Shionogi, Ono, Sumitomo, JT, Nippon Shokubai and more. Applications are due Nov. 17. Learn more.

CIHR invites applicants for its funding competition in partnership with Heart & Stroke, the Research Networks of Excellence in Women’s Heart and/or Brain Health. Learn more.

The National Research Council of Canada has opened applications for its Eureka Network Globalstars Japan 2023-2024. This is an opportunity for Canadian SMEs to collaborate internationally. Applications are due Nov. 13. Learn more.

Start a company over a weekend! Registration is open for entrepreneurship@ubc’s Startup Sprint. This free multi-day boot camp inspires entrepreneurial experiences and skill development among participants by walking through the steps and tools used to assess and build a business. Registration is due Oct. 6. Learn more.

We invite you to explore our expanded list of current life sciences application opportunities by clicking on the following link: Applications Open.

#ICYMI

The Last Word

We are excited to attend next week's MedTech Conference! If you plan to attend, be sure to drop by our booth #225!

Until next week,

Wendy and the LSBC team

Biotalent Canada Named a 2023 Best Workplaces™ in Healthcare

BioTalent Canada has been named one of the country’s Best Workplaces™ in Healthcare for 2023 by Great Place to Work™. “This recognition is a testament to the hard work and enthusiasm of a team dedicated to creating a strong and resilient health and bioscience sector in Canada,” says Rob Henderson, President and CEO of BioTalent Canada. “We will continue to focus on the well-being of our employees, as well as their continued success.”... READ MORE

SFU’s Imagetech Lab Gains New Tech Ally in Advancing Brain Research

The newly installed TRIUX™ neo, from Finland-based neuroscience technology company MEGIN, is providing researchers with access to the latest magnetoencephalography (MEG) technology, furthering their ability to carry out adult and pediatric scans with advanced capabilities... READ MORE

Weight-Loss Drugs Linked to Stomach Paralysis, Other Serious Gastrointestinal Conditions

That’s according to new research from the University of British Columbia showing that medications known as GLP-1 agonists—which includes brands like Wegovy, Ozempic, Rybelsus and Saxenda—are associated with an increased risk of serious medical conditions including stomach paralysis, pancreatitis and bowel obstruction... READ MORE

adMare BioInnovations Appoints John DeLucchi, Martin LeBlanc, and Tim van Biesen to the Board of Directors

adMare BioInnovations is pleased to announce the appointment of John DeLucchi, President & CEO of Madison Venture Corporation, Martin LeBlanc, Co-Founder and Vice-Chairman of CellCarta Biosciences, and Tim van Biesen, head of the Global Healthcare & Life Sciences practice at Bain & Company, to its Board of Directors. Mr. DeLucchi will serve as the Chair of the Finance, Audit & Investment Committee. These additions will bring to adMare a wealth of experience and strategic business acumen acquired in their extensive careers across a multitude of industries... READ MORE

Salix Pharmaceuticals Partners with Bellamy Young

Bausch Health Companies Inc. (NYSE/TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, announced its partnership with award-winning actor Bellamy Young, who is speaking out to help educate people who are impacted by hepatic encephalopathy (HE), caused by cirrhosis. Bellamy wants those affected to know they are not alone and to help them overcome stigma that can interfere with disease education... READ MORE

Public Reimbursement for Biosimilar Byooviz™ to Treat Serious Retinal Disorders Now Secured in Four Provinces and Two National Benefits Programs

Biogen Canada Inc. is pleased to announce that Ontario, New Brunswick, and Prince Edward Island have joined Quebec to reimburse BYOOVIZ™ (ranibizumab injection), an anti-vascular endothelial growth factor (anti-VEGF) biosimilar therapy for certain eye conditions affecting the retina. In addition, BYOOVIZ is now covered by the Non-Insured Health Benefits (NIHB) and Veterans Affairs Canada (VAC) Health Care Benefits programs... READ MORE

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness Through Cedar Clinical Research

Numinus Wellness Inc., a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is proud to introduce its innovative and comprehensive psychedelic program for individuals suffering from mental distress associated with serious and chronic illness. Operating out of the Numinus Wellness UT and Cedar Clinical Research facilities, the program encompasses four key initiatives that showcase Numinus’ commitment to advancing psychedelic research and its potential for healing... READ MORE

Takeda Launches New App to Help Healthcare Professionals Keep Pace with Important Clinical Trial Data

Takeda Canada Inc. announced the launch of Clinical Trials (CT) Lexicon, an innovative app that provides healthcare professionals with a centralized library of key studies and data at their fingertips. The initial launch of the app focuses on Inflammatory Bowel Disease (IBD) with additional clinical focus areas to be rolled-out at later stages... READ MORE

WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers

WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the completion of the strategic transaction (the “Transaction”) with HEALWELL AI Inc. (“HEALWELL”, formerly MCI Onehealth Technologies Inc. (TSX: AIDX))... READ MORE

Avantor® to Host Third Quarter 2023 Earnings Call on Friday, October 27, 2023

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, will release its third quarter 2023 financial results before the market opens on Friday, October 27, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results... READ MORE

Celebrating the Best in Canadian Biotech: BIOTECanada Announces 2023 Gold Leaf Award Winners

The annual BIOTECanada Gold Leaf Awards ceremony was held this week at the National Arts Centre in Ottawa. The awards recognize the remarkable individuals and companies who have made significant contributions to the biotechnology industry and ecosystem in Canada... READ MORE

Filament Health Corp. Announces Non-Brokered Private Placement Unit Offering Led By Negev Capital

 Filament Health Corp., a clinical‐stage natural psychedelic drug development company, today announced that it intends to complete, subject to regulatory approval, a non-brokered private placement for gross proceeds of up to C$2,000,000 (the “Offering”). Negev Capital, a leading venture fund in the psychedelic drug development space, will lead the Offering... READ MORE

InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc., a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the fiscal year ending June 30, 2023 and provided a business update on the pharmaceutical drug development programs as well as the commercial segment for a wholly-owned subsidiary, BayMedica, LLC... READ MORE

Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a potential treatment for post-operative hypothyroidism at the 2023 American Thyroid Association (ATA) Annual Meeting being held in Washington, D.C... READ MORE

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

The updated vaccine is administered as a single dose for individuals 5 years of age and older, regardless of COVID-19 vaccination history. In children 6 months through 4 years of age the vaccine is administered as a three-dose series in those without a history of completion of a COVID-19 primary vaccination course, or as a single dose in those with a history of completion of a COVID-19 primary vaccination course... READ MORE

Takeda Canada was established April 1, 2009 as part of a significant global expansion by Takeda Pharmaceutical Company Limited, a research-based global pharmaceutical company with a 250-year heritage. Takeda is the largest pharmaceutical company in Japan and one of the top 20 pharmaceutical companies worldwide. Takeda Canada’s goal is to bring important medicines to Canadians who need them.

LEARN MORE

Frontier Collective Society Receives $312,000 to Showcase B.C. Innovative Technologies to the World

British Columbia is quickly becoming a burgeoning hub for businesses creating immersive digital technologies. This includes virtual and augmented reality, artificial intelligence, and robotics, which can enhance our world in ways never thought possible. The Government of Canada is making strategic investments in local companies developing innovative technology with a growing global demand. This includes more than 230 immersive technology companies based in British Columbia... READ MORE

The Nobel Prize in Physiology or Medicine 2023

The Nobel Assembly at Karolinska Institutet has decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19. The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19 during the pandemic that began in early 2020... READ MORE

Minister Champagne Announces Corrective Actions After Fact Finding Mission

“Earlier this year, my department, Innovation, Science and Economic Development Canada (ISED) was made aware of allegations of mismanagement at Sustainable Development Technologies Canada (SDTC). ISED immediately decided to conduct a fact-finding exercise through an impartial third party. Last week, I received the report prepared by this third party, Raymond Chabot Grant Thornton (RCGT)"... READ MORE

Minister Ng Participates in the Elevate Festival 2023

The Honourable Mary Ng, Minister of International Trade, Export Promotion, and Economic Development, delivered remarks at the 2023 Elevate Festival, Canada’s largest technology and innovation festival. Minister Ng highlighted the steps the Government of Canada is taking to even the economic and entrepreneurship playing fields for all Canadians, focusing on federal support for women entrepreneurs and Canada’s inclusive approach to trade... READ MORE

Report Shows Pathway to Improve Credential Recognition Process

The Province is releasing a new report that shows professional regulatory bodies made changes to improve credential-recognition processes for internationally trained professionals. The review was carried out by the Office of the Superintendent of Professional Governance, which oversees regulatory bodies outside the health sector... READ MORE

Quality System Specialist

To succeed in this role, the applicant must be a strong Quality partner/ collaborator to drive operational efficiencies to achieve sustainable quality compliance and meet the business objectives of the site. Build strong relationships with the Quality team, internal stakeholders (such as Development & Formulation, Supply Chain, Project Management, etc.) and external suppliers to assure on-time delivery of products/ materials/ services that are quality compliant and fit for its intended purpose...LEARN MORE

Research Associate-Protein Biochemistry

Abdera Therapeutics is seeking a highly motivated and skilled Research Associate in antibody discovery programs. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Senior Scientist Biologics

Abdera Therapeutics is seeking a highly motivated and skilled Senior Scientist in antibody discovery programs with a proven track record of research accomplishments. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Research Associate II, Analytics

The candidate should have expertise in high-performance liquid chromatography (HPLC), mass spectrometry, and protein biochemistry for protein characterization. Experience with various extraction techniques, Agilent™ or Waters™ HPLC and mass spectrometry equipment, AKTA™ purification systems, biological matrices like plasma and serum, and Orbitrap™ mass spectrometry instrumentation would be advantageous. General knowledge of antibody and antibody drug conjugate structure/function is also considered a valuable asset...LEARN MORE

Animal Research Associate II

This role involves applying preclinical mouse pharmacology models for cancer therapy research. Responsibilities include handling mice for various procedures, preparing drugs using sterile techniques, managing human immune cell injections, coordinating sample handling, maintaining records, and ensuring adherence to scientific standards and regulations. Effective organization, teamwork, and adherence to established protocols are essential, while fostering collaborative relationships with colleagues and management is encouraged...LEARN MORE

Senior Research Associate I, In Vitro Pharmacology

This position involves planning and executing advanced experiments, troubleshooting methods, and independently analyzing and interpreting data. The role includes designing animal studies, contributing to project planning and coordination, staying updated on relevant scientific literature, maintaining inventory databases, and potentially training junior staff. The candidate is expected to adhere to scientific standards, safety regulations, and lab protocols while actively contributing to collaborative work environments and potentially co-authoring scientific papers...LEARN MORE

Scientist, DMPK/ADME

If you are selected for this position, you will be lead oversight of contract research partners and in-house development of in vitro DMPK assays, contributing to their optimization and methodology enhancement. Independently design experiments for assessing pharmacokinetics and pharmacodynamics of small molecules and ADCs, establishing in vitro to in vivo correlations, and collaborating across disciplines to advance drug development programs. Maintain up-to-date knowledge in drug metabolism and pharmacokinetics, adhere to data generation protocols, and foster collaborative relationships with colleagues and management...LEARN MORE

Associate Scientist, In Vivo Pharmacology

The ideal candidate should have expertise in xenograft, syngeneic, or humanized mouse tumor models (PBMC/CD34) and a strong grasp of immune cell function. Proficiency in animal handling, dosing, and sample collection, especially tail vein injections, is essential. They should also demonstrate knowledge of in vivo cancer models, antibody-based therapeutics, immune cell isolation, strong organizational skills, experience with contract research organizations, and effective teamwork within scientific project teams...LEARN MORE

Controller

The Employee will carry out standard job responsibilities and any additional tasks assigned by the Company, including financial management, policy enforcement, budgeting, tax coordination, audit oversight, control maintenance, reporting enhancement, compliance support, variance analysis, insurance management, stock options, governance assistance, benefits administration, and other duties as directed by the CFO and Executives...LEARN MORE

Quality Assurance Specialist

Filament Health is looking for an enthusiastic individual with a keen eye for detail to fill the role of Quality Assurance Specialist with experience in the pharmaceutical industry. Reporting to the Quality Director, the ideal candidate will be a self-starter who needs minimal oversight and thrives in a dynamic work environment. They will provide quality support to ensure adherence to Good Documentation and Production Practices, Health Canada regulations as well as international jurisdictions such as the US, EU, UK and Australia...LEARN MORE

Project Coordinator, Research and Innovation (R&I)

As the Project Manager for Research and Innovation (R&I) Agrifood and Natural Resources (ANR), you will primarily provide project management and administrative support to the R&I Senior Manager, ANR. Additionally, you will informally report to the Director of Operations to ensure alignment with processes and effective reporting of any issues that may arise during project management...LEARN MORE

Events Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to assist with

preparations and execution of both in-person and virtual events. With several scheduled events happening between January and April, this role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Events...LEARN MORE

Partnerships & Memberships Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to help maximize potential revenue opportunities and lead generation throughout the term. This role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Partnerships and Memberships...LEARN MORE

Marketing & Communications Specialist (Co-op Student)

In this limited-term role, you'll work alongside our Marketing and Communications Manager, contributing your skills to the planning and execution of diverse marketing and communications initiatives. This is an exceptional chance to acquire practical expertise while leaving your mark on both the life sciences field and the world of marketing and communications...LEARN MORE

Vice President, Corporate Development

The VP, Corporate Development supports the delivery of the corporate mandate in close cooperation with other members of the management team by: building relationships with key stakeholders, including government; delivering cross-functional programs and initiatives; and, taking the lead on emerging opportunities...LEARN MORE

Canada’s Immuno-Engineering and Biomanufacturing Hub - Industry Partnership Manager

Working under broad directions of the Executive Director of CIEBH, the Industry Partnership Manager will develop and mobilize academic and hospital discoveries originating from the University and its Affiliated Hospitals, through fostering sponsored research, supporting entrepreneurship, developing and implementing knowledge mobilization plans, engaging with researchers and industry, and conducting evaluations...LEARN MORE

Scientist, Preclinical Research

Bold Therapeutics is seeking to hire a Scientist to join and expand their preclinical research team. A successful candidate will support Bold Therapeutics’ preclinical oncology research efforts, with a focus on cellular biology and understanding the mechanism of action of BOLD-100 and our other metallotherapeutics. The role involves collaborating with Bold Therapeutics’ research team, as well as our network of academic and industry partners, to advance the understanding of our key assets...LEARN MORE

Postdoctoral Position at Eyam Vaccines and Immunotherapeutics - Bioinformatician

This is a unique opportunity to experience collaborative research with leading industry and academic experts. The successful candidate will work both in-person, on site at our Vancouver/Greater Vancouver Area offices, and remotely on a project to create and use novel algorithms for the development of self-amplifying nucleic acid vaccines...LEARN MORE

Animal Technician

Alpha-9 is seeking a team-oriented Animal Research Technician to join the Translational Biology group within the organization. The ideal candidate will have experience in providing technical in vivo support for research programs, preferably with radioactive substances. This person will be responsible for laboratory animal care and well-being, in addition to conducting in vivo research experiments with experimental radiopharmaceuticals...LEARN MORE

Tenure-Track Assistant Professor Positions (2) Nanomedicine or Chemical Biology

UBC is seeking two full-time tenure-track Assistant Professor positions in their Nanomedicine and Chemical Biology Research Theme, where the research programs focus on many aspects of drug discovery, development and delivery. The major focus of this position will be the development of a cutting-edge, externally-funded, world-class research program. Other responsibilities will include teaching nanomedicine/drug delivery or chemical biology and other related topics to students in the BPSc, PharmD, and MSc/PhD programs, as well as new programs under development...LEARN MORE

SmartMom is a Canadian prenatal education program that provides trustworthy educational text messages to help guide you through the weeks of your pregnancy.

Our information is current, evidence-based and has been developed by maternal and child health experts. We will suggest topics to discuss with your health care provider and offer recommendations for more information and resources available online and in your own community. LEARN MORE

CereCura Nanotherapeutics is a preclinical neuroscience-focused biotechnology company developing lipid nanoparticle-RNA therapies for a wide range of brain disorders.

CereCura’s disease-agnostic approach aims to overcome barriers to CNS therapeutics by harnessing the brain to produce its own medicine. Our mission is to pioneer a novel class of genetic drugs for untreated brain disorders. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!